A detailed history of Seven Mile Advisory transactions in Pfizer Inc stock. As of the latest transaction made, Seven Mile Advisory holds 6,938 shares of PFE stock, worth $182,885. This represents 0.13% of its overall portfolio holdings.

Number of Shares
6,938
Holding current value
$182,885
% of portfolio
0.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $192,182 - $217,783
6,938 New
6,938 $201 Million
Q1 2024

May 08, 2024

SELL
$25.89 - $29.73 $61,074 - $70,133
-2,359 Reduced 22.56%
8,096 $225 Million
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $14,005 - $18,191
536 Added 5.4%
10,455 $301 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $28,945 - $33,834
902 Added 10.0%
9,919 $329 Million
Q2 2023

Aug 08, 2023

BUY
$36.12 - $41.79 $325,694 - $376,820
9,017 New
9,017 $331 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Seven Mile Advisory Portfolio

Follow Seven Mile Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Mile Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Seven Mile Advisory with notifications on news.